The FDA acted six months after an independent lab warned the FDA of a potential carcinogen in ranitidine drugs and nearly three months after another lab told the FDA its tests determined levels of ...

you might by the time you walk out after trying to figure out which drug to buy. To take the guesswork out of shopping for over-the-counter drugs, we asked our experts to choose the best ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

Delaware’s highest court agreed to hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer, Reuters writes.

But for certain common ailments, our Consumer ­Reports Best Buy Drugs analysis shows that over ... such as famotidine (Pepcid AC and generic) and ranitidine (Zantac 75, Zantac 150, and generic).

GSK Plc shares rose on Wednesday, buoyed by a US court’s decision to review whether evidence supporting claims that heartburn drug Zantac causes cancer is scientifically sound. The British ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused ...

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...

The US state of Delaware's highest court will hear an appeal by GSK and other drugmakers seeking to end over 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer. The ...

The litigation at the center of this legal battle revolves around allegations that ranitidine, the active ingredient in Zantac, may be linked to an increased risk of cancer. “In our view ...

Delaware Top Court Will Hear Drugmakers' Appeal to End Zantac Lawsuits By Brendan Pierson (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers ...

Delaware’s highest court agreed to hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer, Reuters writes.